Friday, July 18th, 2025

Clearbridge Health Limited Completes Rights Issue: 1.24 Billion New Shares to Begin Trading on SGX Catalist








Clearbridge Health’s Major Share Expansion: What Investors Need to Know

Clearbridge Health’s Major Share Expansion: What Investors Need to Know

Clearbridge Health Limited has announced a significant development in its capital structure through a renounceable non-underwritten rights issue. The company has allotted and issued a massive 1,239,482,704 new ordinary shares, as of December 10, 2024, increasing the total number of issued shares from 619,741,352 to 1,859,224,056. This represents a substantial growth in the company’s share capital, which is crucial information for stakeholders.

The new shares are expected to be credited to shareholders’ securities accounts by December 12, 2024, and they will be listed and commence trading on the Catalist board of the SGX-ST from 9:00 a.m. the same day. Notably, these rights shares will rank pari passu with existing shares, except for dividends or distributions with a record date prior to their issuance.

Shareholders should be aware of the trading implications, especially regarding odd lots. On the SGX-ST’s Catalist board, each board lot comprises 100 shares. Shareholders holding odd lots, which do not form complete board lots, can trade these on the Unit Share Market. However, the market for odd lot trading may be illiquid, and there is no assurance of acquiring or disposing of such shares easily.

This expansion in share capital could have significant implications for shareholders and potential investors, potentially impacting share prices. As the company enhances its capital base, market participants should closely monitor trading volumes and pricing trends post-issuance.

By Order of the Board, Executive Director and CEO Yee Pinh Jeremy confirmed the details on December 11, 2024. The announcement has been reviewed by the company’s sponsor, ZICO Capital Pte. Ltd., but not by the Singapore Exchange Securities Trading Limited, which assumes no responsibility for the announcement’s contents.

Disclaimer: The information provided in this article is intended for informational purposes only and should not be considered financial advice. Investors are advised to conduct their own research or consult with a financial advisor before making investment decisions.




View Clearbridge Historical chart here



OneApex Limited Announces 9.5% Dividend Payout for Shareholders in February 2025

OneApex Declares Generous Final and Special Dividends, Shareholders Take Note OneApex Declares Generous Final and Special Dividends, Shareholders Take Note OneApex Limited, a Singapore-based company, has announced a substantial payout for its shareholders, comprising...

TrickleStar Announces Record Date for 4-for-5 Rights Issue: Key Details for Shareholders

TrickleStar Rights Issue: Key Details Every Investor Must Know TrickleStar Rights Issue: Key Details Every Investor Must Know TrickleStar Limited, a Singapore-based company (Registration No. 201837106C), has announced details of its proposed renounceable non-underwritten...

QAF Limited FY2024 Final Dividend Record Date Announcement

Title: QAF Limited Announces Upcoming Final Dividend for FY2024 – Key Details Investors Need to Know Article: Highlights: QAF Limited, a Singaporean company, has announced the record date for its FY2024 final dividend of...